Details for New Drug Application (NDA): 091454
✉ Email this page to a colleague
The generic ingredient in LARIN FE 1/20 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 091454
Tradename: | LARIN FE 1/20 |
Applicant: | Novast Labs |
Ingredient: | ethinyl estradiol; norethindrone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 091454
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LARIN FE 1/20 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 091454 | ANDA | Northstar Rx LLC | 16714-406 | 16714-406-01 | 1 BLISTER PACK in 1 PACKET (16714-406-01) / 1 KIT in 1 BLISTER PACK |
LARIN FE 1/20 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 091454 | ANDA | Northstar Rx LLC | 16714-406 | 16714-406-02 | 1 BLISTER PACK in 1 CARTON (16714-406-02) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.02MG;1MG | ||||
Approval Date: | Aug 26, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription